e-Drug3D 959 |
REGADENOSON
|
cas 313348-27-5 |
CLASS CARDIOVASCULAR |
ROUTE (list) INTRAVENOUS |
ATC code |
PK parameters Tmax 0.08 HOUR |
Target TARGET A2A ADENOSINE RECEPTOR |
DrugCentral Adenosine receptor A2a UNIPROT P29274 ADORA2A |
Download SDF file | Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]- Formula: Calculated chemical properties: MW 390.37 NB_atoms 28 XLogP -2.43 PSA 177.258 NB_HD 6 NB_HA 13 fsp3 0.40 Lipinski(0=no;1=yes) 0 |
FDA NDA 022161 (label) INN (REGADENOSON) LEXISCAN (ASTELLAS) APPROVAL= AP YEAR= 2008 NDA 207604 (pdf not found) INN (REGADENOSON) REGADENOSON (APOTEX) APPROVAL= AP YEAR= 2022 NDA 213210 (pdf not found) INN (REGADENOSON) REGADENOSON (DR REDDYS) APPROVAL= AP YEAR= 2022 NDA 212806 (pdf not found) INN (REGADENOSON) REGADENOSON (MEITHEAL) APPROVAL= AP YEAR= 2022 NDA 213236 (pdf not found) INN (REGADENOSON) REGADENOSON (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022 NDA 214252 (pdf not found) INN (REGADENOSON) REGADENOSON (IMS LTD) APPROVAL= AP YEAR= 2022 NDA 207320 (pdf not found) INN (REGADENOSON) REGADENOSON (GLAND) APPROVAL= AP YEAR= 2022 NDA 214349 (pdf not found) INN (REGADENOSON) REGADENOSON (HOSPIRA) APPROVAL= AP YEAR= 2022 NDA 216437 (pdf not found) INN (REGADENOSON) REGADENOSON (EUGIA PHARMA) APPROVAL= AP YEAR= 2022 NDA 213856 (pdf not found) INN (REGADENOSON) REGADENOSON (MYLAN) APPROVAL= AP YEAR= 2023 NDA 215827 (pdf not found) INN (REGADENOSON) REGADENOSON (HIKMA) APPROVAL= AP YEAR= 2023 NDA 217455 (pdf not found) INN (REGADENOSON) REGADENOSON (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2023 NDA 215955 (pdf not found) INN (REGADENOSON) REGADENOSON (GE HEALTHCARE) APPROVAL= AP YEAR= 2024 NDA 218054 (pdf not found) INN (REGADENOSON) REGADENOSON (INDIES PHARMA) APPROVAL= AP YEAR= 2024 |
Other links: |